Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Br J Ophthalmol ; 104(9): 1298-1303, 2020 09.
Article in English | MEDLINE | ID: mdl-31959588

ABSTRACT

AIM: To comprehensively examine the association between kidney function and primary open angle glaucoma (POAG) in a large consortium of multiple Asian population-based studies. METHODS: 28 925 participants (57 340 eyes) from 9 population-based studies (from China, Hong Kong, India, Korea, Russia, Singapore) of the Asian Eye Epidemiology Consortium were included. Across all studies, POAG was defined based on the International Society of Geographical and Epidemiological Ophthalmology criteria. Estimated glomerular filtration rate (eGFR) was calculated from serum creatinine. Chronic kidney disease (CKD) was defined as eGFR<60 mL/min/1.73 m2. Eye-specific data were pooled from each study. Multivariable regression analysis with generalised estimating equation models was performed to evaluate the associations between kidney function with POAG and intraocular pressure (IOP). RESULTS: After adjusting for age, gender, study group, hypertension, diabetes, hyperlipidaemia, body mass index, smoking status and IOP, lower eGFR (per 10 mL/min/1.73 m2 decrease) was not significantly associated with POAG (OR=1.01; p=0.77). Presence of CKD was also not significantly associated with POAG (OR=1.01; p=0.739). Furthermore, lower eGFR and presence of CKD were not associated with IOP (all p≥0.12), However, in the subgroup of combined Korean and Chinese individuals, significant associations between lower eGFR (OR=1.09; 95% CI 1.00 to 1.18; p=0.048) and severe kidney function decline (<45 mL/min/1.73 m2; OR=2.57; 95% CI 1.34 to 4.93; p=0.004) with POAG, were observed. CONCLUSION: In this large pooled-analysis of multiple Asian population-based studies, our findings suggest that the association between CKD and POAG may only be present in East Asians specifically but not in the overall Asian population. Further evaluation in Japanese population is warranted to confirm this observation.


Subject(s)
Glaucoma, Open-Angle/physiopathology , Kidney/physiopathology , Adult , Aged , Asia/epidemiology , Asian People/statistics & numerical data , Cross-Sectional Studies , Epidemiologic Studies , Female , Glaucoma, Open-Angle/epidemiology , Glomerular Filtration Rate , Humans , Intraocular Pressure/physiology , Male , Middle Aged , Renal Insufficiency, Chronic/epidemiology , Renal Insufficiency, Chronic/physiopathology , Tonometry, Ocular , Visual Field Tests , Visual Fields/physiology
2.
Ocul Immunol Inflamm ; 27(1): 64-69, 2019.
Article in English | MEDLINE | ID: mdl-29020487

ABSTRACT

PURPOSE: To identify the clinical features and prognostic factors of uveitis associated with ankylosing spondylitis (AS). METHODS: This retrospective, interventional case series study reviewed the medical records of 91 AS patients with uveitis. RESULTS: The characteristics of AS-associated uveitis included male preponderance (70%), average onset in the fourth decade, unilateral manifestation (87.9%), and vitreous involvement or retinal vascular leakage (36.3%). All patients had acute anterior uveitis. The best corrected visual acuity in logMAR improved from 0.8 ± 0.3 to 0.1 ± 0.2. The use of biologic agents was the only significant factor in the multivariate analysis. Patients with vitreous involvement/retinal vascular leakage were more likely to use systemic/peribulbar steroids for inflammation control, and achieved equally favorable visual outcome as in those without vitreous involvement/retinal vascular leakage. CONCLUSION: The clinical characteristics and profile of visual prognostic factors suggest an association between the severity of ocular inflammation and systemic disease.


Subject(s)
Spondylitis, Ankylosing/diagnosis , Uveitis, Anterior/diagnosis , Acute Disease , Adolescent , Adult , Female , Fluorescein Angiography , Glucocorticoids/therapeutic use , Humans , Male , Middle Aged , Mydriatics/therapeutic use , Prognosis , Retinal Vasculitis/diagnosis , Retinal Vasculitis/physiopathology , Retrospective Studies , Spondylitis, Ankylosing/drug therapy , Spondylitis, Ankylosing/physiopathology , Uveitis, Anterior/drug therapy , Uveitis, Anterior/physiopathology , Vision Disorders/diagnosis , Vision Disorders/physiopathology , Visual Acuity/physiology , Young Adult
3.
Am J Ophthalmol ; 158(6): 1205-1214.e7, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25149910

ABSTRACT

PURPOSE: To investigate the prevalence of and risk factors associated with dry eye syndrome (DES) in South Korea. DESIGN: Cross-sectional study. METHODS: In 2010 and 2011, 11,666 subjects, ranging in age from 19 to 95, were randomly selected as nationally representative participants in the Korea National Health and Nutrition Examination Survey (KNHANES). Subjects were divided into 2 groups: 1 with clinically diagnosed DES and 1 with symptoms of dry eye. We determined the prevalence of and risk factors for dry eyes in a Korean population. Health-related quality of life (HRQoL), measured by the EuroQoL-5 dimension (EQ-5D), was evaluated in patients with dry eyes. RESULTS: The mean age was 49.9 years. The overall prevalence of diagnosed DES was 8.0% (95% confidence interval [CI], 7.3% to 8.7%), and of dry eye symptoms the prevalence was 14.4% (95% CI, 13.1 to 15.7). Age (adjusted odds ratio [aOR] = 1.8, 1.6), female (aOR = 2.8, 1.9); history of eye surgery (aOR = 2.6, 2.2); stress (aOR = 1.7, 1.6); thyroid disease (aOR = 1.7, 1.5); and high education level (aOR = 1.6, 1.5) were common risk factors in the groups. Subjects who had undergone ptosis, cataract or refractive surgery were more likely to have dry eye than subjects with no history of eye surgery. Means of pain and anxiety dimensions in the EQ-5D and the Euro Quality of Life Visual Analog Scale (EQ-VAS) were significantly higher in the group with diagnosed DES than in the normal group. CONCLUSIONS: The risk factors were mostly similar in both groups. It is thought there are more patients with DES who have not been diagnosed by doctors. Doctors should identify whether a patient has any risk factors for dry eye. Patients need to be educated about the modifiable factors of DES.


Subject(s)
Dry Eye Syndromes/epidemiology , Adult , Age Distribution , Aged , Aged, 80 and over , Cross-Sectional Studies , Dry Eye Syndromes/psychology , Female , Health Status , Humans , Male , Middle Aged , Nutrition Surveys/statistics & numerical data , Odds Ratio , Prevalence , Quality of Life/psychology , Republic of Korea/epidemiology , Risk Factors , Rural Population/statistics & numerical data , Sex Distribution , Sickness Impact Profile , Urban Population/statistics & numerical data , Young Adult
4.
J Ocul Pharmacol Ther ; 30(5): 381-6, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24724576

ABSTRACT

PURPOSE: To demonstrate that ultraviolet-A (UV-A) and voriconazole combination therapy is more effective than voriconazole single treatment for fungal keratitis. METHODS: The in vitro UV-A (375 nm) fungicidal effect was evaluated on Fusarium solani solutions. Each fungal solution was irradiated with different UV-A irradiation doses. Also, a fungal solution containing voriconazole was also irradiated with UV-A. The in vivo therapeutic effect of UV-A and voriconazole treatment was studied in a rabbit keratitis model. Fungi were injected intrastromally into the cornea of 16 rabbits. Each treatment was initiated 3 days after fungal injection and continued up to 8 days for the following groups: Group 1, control; Group 2, treated with UV-A once a day; Group 3, treated with voriconazole 3 times a day; Group 4, treated with voriconazole 3 times a day and UV-A once a day. On the last day, the sclera-cornea buttons were extracted and microbiological and histological evaluations were performed. RESULTS: The colony-forming units (CFUs) of fungal solutions in culture significantly decreased with UV-A irradiation. The CFUs of fungal solutions containing voriconazole also decreased with UV-A irradiation. In vivo, clinical scores of Group 3 (P=0.03) and Group 4 (P=0.02) 5 days after treatment were significantly lower compared to that of Group 1. The clinical score of Group 4 (P=0.03) 5 days after treatment was significantly lower compared to that of Group 3. The histopathological scores 5 days after treatment were significantly lower in Group 4 compared to those of Group 1 (P<0.01) and Group 3 (P=0.02). Based on our CFU analysis, only Group 4 showed significantly lower CFUs compared to Group 1 (P=0.04). CONCLUSIONS: UV-A and voriconazole combination treatment could be a safe and effective alternative to voriconazole single treatment for fungal keratitis.


Subject(s)
Eye Infections, Fungal/therapy , Fusariosis/therapy , Fusarium/isolation & purification , Keratitis/therapy , Ultraviolet Therapy/methods , Voriconazole/administration & dosage , Animals , Antifungal Agents/administration & dosage , Combined Modality Therapy/methods , Eye Infections, Fungal/pathology , Fusariosis/pathology , Fusarium/drug effects , Fusarium/radiation effects , Humans , Keratitis/pathology , Rabbits , Treatment Outcome
5.
BMC Ophthalmol ; 14: 4, 2014 Jan 10.
Article in English | MEDLINE | ID: mdl-24410920

ABSTRACT

BACKGROUND: To assess the socio-demographic and health-related risk factors associated with cataract subtypes in Korea. METHODS: A total of 11,591 participants (aged ≥40 years) were selected from the Korean National Health and Nutrition Examination Survey between 2008 and 2010. The Korean Ophthalmologic Society conducted detailed ophthalmologic examinations on these participants based on the Lens Opacity Classification System III. Risk factors for developing any type of cataract, and its subtypes (nuclear, cortical, posterior subcapsular and mixed), were identified from univariate and multivariate logistic regression analysis. RESULTS: The prevalence of cataracts was 40.1% (95% CI, 37.8 - 42.3%) in participants over 40 years old. Older age, lower monthly household income, lower education, hypercholesterolemia, hypertension, and diabetes mellitus (DM) were independent risk factors for development of any cataract. Older age, lower monthly household income, lower education, hypercholesterolemia, and DM were independent risk factors for development of pure cortical cataracts. Older age, lower education, metabolic syndrome, and DM were independent risk factors for development of pure nuclear cataracts. Older age and DM were independent risk factors for development of pure posterior subcapsular cataracts. Older age, lower monthly household income, lower education, and DM were independent risk factors for development of mixed cataracts. CONCLUSION: Although socioeconomic disparities are related to cataract development, this study identified several "modifiable" risk factors that may help to lower the incidence of cataracts and associated vision loss. Improved control of blood pressure, blood, glucose, and cholesterol may help to reduce the incidence of cataracts in the general Korean population.


Subject(s)
Cataract/epidemiology , Adult , Age Factors , Aged , Aged, 80 and over , Cataract/classification , Cataract/etiology , Diabetes Mellitus/epidemiology , Educational Status , Female , Humans , Hypercholesterolemia/epidemiology , Hypertension/epidemiology , Income , Korea/epidemiology , Logistic Models , Male , Middle Aged , Risk Factors , Socioeconomic Factors
7.
J Korean Med Sci ; 28(6): 814-20, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23772143

ABSTRACT

This cross-sectional study was done to identify and determine the socio-demographic and health-related factors associated with diabetic retinopathy and nephropathy screening in Korea. Participants included 2,660 adults, aged 40 or older, with diabetes. Of the 2,660 adults, 998 (37%) and 1,226 (46.1%) had received a diabetic retinopathy and a nephropathy screening within one year, respectively. Regarding retinopathy, subjects older than 65, living in urban areas, with high educational levels, and with self-reported "unhealthy" status were likely to receive annual screening. Subjects living in urban areas, with higher educational levels, with self-reported "fair" or "unhealthy" status, and with 1 to 2 co-morbidities were likely to receive annual nephropathy screening. The Korea Composite Stock Price Index (KOSPI) continued to rise until 2007 when it started to decline over the subsequent years, following the same curve as the diabetic retinopathy and nephropathy screening rates during that time. Together with the financial matter, lack of patient education proved to be a hindrance to diabetes-related screening. The relatively low screening rates in Korea compared to the Western countries are likely to be due to the difference in the health system, economic situations and national demographics.


Subject(s)
Diabetic Nephropathies/etiology , Diabetic Retinopathy/etiology , Adult , Aged , Cross-Sectional Studies , Diabetes Complications/pathology , Diabetes Mellitus/diagnosis , Diabetic Nephropathies/diagnosis , Diabetic Retinopathy/diagnosis , Female , Health Behavior , Health Status , Humans , Male , Mass Screening , Middle Aged , Nutrition Surveys , Odds Ratio , Republic of Korea , Risk Factors , Severity of Illness Index
8.
Am J Ophthalmol ; 156(1): 36-42.e1, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23540709

ABSTRACT

PURPOSE: To describe the clinical characteristics of ciliary body tumors, surgical outcomes, and factors associated with poor visual outcome and metastasis. DESIGN: Retrospective case series. METHODS: Medical records of 27 patients with ciliary body tumors who underwent partial lamellar sclerouvectomy in a single-center setting (Seoul, South Korea) were reviewed. Surgical outcomes were reviewed, and clinical characteristics were analyzed with respect to visual prognosis and globe retention rate. RESULTS: Tumors were diagnosed histopathologically as benign in 8 (30%) cases and as melanoma in 19 (70%) cases. Patients had a median age of 48 years. The median follow-up was 3.5 years (range, 0.5 to 6 years). The tumors had a median diameter of 11 mm and a median thickness of 9 mm. The globe was retained in 20 (74%) eyes, with visual acuity of 20/400 or better in 13 (48%) eyes and 20/40 or better in 6 (22%) eyes. Choroidal involvement of tumor (P = .003), larger diameter of tumor (P < .001), and thicker tumor (P < .001) were associated with poor visual outcome. Local recurrence (P = .003) and presence of epithelioid cells (P = .040) were predictive factors for metastasis in melanoma patients. Kaplan-Meier estimates of metastasis-free survival at 3 and 5 years for melanoma patients were 82% and 55%, respectively. CONCLUSIONS: Partial lamellar sclerouvectomy is a reasonable primary therapeutic option in ciliary body tumors, and good visual prognosis is expected in selected cases.


Subject(s)
Ciliary Body/surgery , Melanoma/surgery , Neoplasm Recurrence, Local/diagnosis , Ophthalmologic Surgical Procedures , Sclera/surgery , Uveal Neoplasms/surgery , Adolescent , Adult , Aged , Aged, 80 and over , Asian People , Child , Ciliary Body/pathology , Disease-Free Survival , Female , Follow-Up Studies , Humans , Korea , Male , Melanoma/secondary , Middle Aged , Retrospective Studies , Surgical Flaps , Treatment Outcome , Uveal Neoplasms/pathology , Visual Acuity/physiology , Young Adult
9.
Cornea ; 32(7): 962-70, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23442251

ABSTRACT

PURPOSE: To assess the sociodemographic and health-related risk factors associated with pterygium and its subtypes in Korea. METHODS: From 2008 to 2010, a total of 14,920 randomly selected national representative participants of the Korean National Health and Nutrition Examination Survey underwent additional ophthalmologic examinations by the Korean Ophthalmologic Society. The risk factors for pterygium in general or according to subtype (atrophic, intermediate, and fleshy) were identified using multivariate logistic regression analysis. RESULTS: The prevalence of pterygium was 6.7% (95% confidence interval, 5.9-7.5) in subjects aged 30 years or older. Older age, male sex, lower educational level, rural habitation, nonsmoking, and sun exposure were independent risk factors for pterygium. Among subjects with pterygium, older age, male sex, lower educational level, and nonsmoking were independent risk factors for all types of pterygium. Sun exposure for >5 h/d was the independent risk factor for the severe pterygium subtype. CONCLUSIONS: Socioeconomic disparities in pterygium development exist. Proper ocular examination and education to avoid excessive sun exposure would be helpful in reducing disease risk.


Subject(s)
Nutrition Surveys/statistics & numerical data , Pterygium/epidemiology , Adult , Age Factors , Aged , Educational Status , Environmental Exposure , Female , Humans , Korea/epidemiology , Male , Middle Aged , Prevalence , Pterygium/classification , Risk Factors , Rural Population/statistics & numerical data , Sex Factors , Smoking/epidemiology , Sunlight
10.
Graefes Arch Clin Exp Ophthalmol ; 251(1): 261-70, 2013 Jan.
Article in English | MEDLINE | ID: mdl-22968823

ABSTRACT

BACKGROUND: To evaluate the efficacy of subconjunctival triamcinolone injection for treating upper eyelid retraction caused by thyroid-associated ophthalmopathy (TAO). METHODS: Prospective single blind randomized clinical trial. Patients diagnosed with TAO-associated eyelid retraction and/or swelling <6 months before study onset were randomly assigned to triamcinolone-injected (group I; 55 patients, 75 eyes) or observation-only (group II; 40 patients, 59 eyes) populations. Group I received 1-3 injections of 20 mg triamcinolone acetate into the subconjunctival eyelid, between the conjunctiva and Muller's muscle, at 3-week intervals. Group I was followed up at 3, 6, 9, and 24 weeks post-injection, and group II was evaluated at 9 and 24 weeks after initial visit. Eyelid swelling and retraction were each graded on a 0-3 scale. Treatment was stopped after 1-2 injections if both swelling and retraction resolved completely or if retraction and swelling scored 0/1 or 1/0 without functional or cosmetic patient concerns. Treatment success was defined at 9 and 24 weeks post-injection if eyelids were normal or when treatment was terminated because of early clinical resolution. We compared baseline clinical data between success and failure group evaluated at 9 and 24 weeks in group I, and investigated short-term and long-term success prognostic factor using multiple logistic regression analysis in each group I and II. RESULTS: Swelling and retraction decreased significantly more in group I than in group II. Significantly more eyes had severe swelling (≥ grade 2) in group I (67 %) than in group II (34 %) upon initial evaluation (p < 0.01); this difference disappeared at 9 and 24 weeks. Fewer severely retracted eyes were observed in group I than in group II at 9 and 24 weeks (p < 0.01). Significantly more eyes in group I achieved success at both 9 and 24 weeks (59 %, 75 %) than in group II (39 %, 57 %) (p = 0.03, p = 0.04 respectively). Higher initial retraction grades (2-3) predicted a higher chance of post-injection failure versus the reference group (grade 0-1) at 9 and 24 weeks in group I, with adjusted odds ratios (aOR) 45.4 (95 % CI = 5.9-351.1, p < 0.01) and aOR 11.6 (95 % CI = 2.3-58.5, p < 0.01) respectively. Similarly in group II, initial retraction grade was associated with the failure at 9 and 24 weeks, with aOR 10.3 (95 % CI = 1.8-59.6, p < 0.01) and aOR 5.9 (95 % CI = 1.3-25.9, p < 0.05) respectively. Transient intraocular pressure elevation was observed in three eyes of two patients, although all ocular pressures were normalized within 1 month using anti-glaucoma medication. CONCLUSIONS: Subconjunctival triamcinolone injections were very effective in resolving eyelid swelling and retraction in recent-onset TAO. However, the symptom-reducing effect of triamcinolone was modest and less effective in patients initially presenting with severe retraction grades. As intraocular pressure may rise after steroid injection at upper eyelid, the treatment should be avoided in patients suspected to have glaucoma.


Subject(s)
Eyelid Diseases/drug therapy , Glucocorticoids/therapeutic use , Graves Ophthalmopathy/drug therapy , Triamcinolone Acetonide/therapeutic use , Adult , Aged , Conjunctiva , Eyelid Diseases/classification , Eyelid Diseases/etiology , Female , Follow-Up Studies , Glucocorticoids/administration & dosage , Glucocorticoids/adverse effects , Graves Ophthalmopathy/complications , Humans , Injections, Intraocular , Intraocular Pressure/drug effects , Male , Middle Aged , Prospective Studies , Single-Blind Method , Treatment Outcome , Triamcinolone Acetonide/administration & dosage , Triamcinolone Acetonide/adverse effects , Visual Acuity/physiology , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL